查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1511977

感染疾病體外診斷市場規模、佔有率、趨勢分析報告：按產品、技術、應用、測試地點、地區、細分市場預測，2024-2030年

Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Software), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 190 Pages | 商品交期: 2-10個工作天內

價格

感染疾病體外診斷市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球感染疾病體外診斷市場規模將達280.5億美元，預測期內複合年成長率為2.4%。

結核病和 COVID-19 等感染疾病患者的上升以及技術進步預計將推動未來幾年的產品需求。多重抗藥性感染疾病的增加加強了感染疾病的早期診斷。例如，根據 2021 年微生物抗藥性雜誌報告，重症 SARS-CoV-2 患者中 MDR感染疾病的盛行率在 14% 至 50% 之間。

感染前診斷和抗生素治療的延誤進一步加劇了抗藥性細菌的傳播，並為產業成長創造了利潤豐厚的機會。該行業推出了眾多產品來滿足消費者的需求。例如，2022年5月，BD在美國推出了感染疾病自動化診斷平台。該系統可裝載 1700 個檢體，無需對檢體進行分類，從而減少錯誤。各個競爭公司提供的產品都經過策略性定價，以增加競爭公司之間的對抗關係。

然而，當消費者由於敏感性和信念的差異而不得不在 PoC 測試和基於實驗室的測試之間進行選擇時，購買行為的複雜性顯著增加。該行業呈寡頭壟斷，霍夫曼-拉羅氏、阿萊爾、生物梅里埃和BD等公司佔據了大部分市場佔有率。全球產業對價格敏感，在製造具有成本效益和高效的產品方面造成參與者之間的激烈競爭。由於預計將推出新的生物標記套件，競爭對手之間的敵意預計將在預測期內增加。競爭對手正在採取重要策略，例如產品發布和宣傳計劃，以獲取更高的市場佔有率。

感染疾病體外診斷市場報告亮點

  • 由於檢測中的大量使用，試劑產品細分市場在 2023 年佔據最大的銷售佔有率。
  • 分子診斷細分市場在 2023 年佔據最大佔有率，因為該細分市場推出的產品數量不斷增加，並且由於其高精度而採用率不斷提高。
  • 從應用來看，2023 年，COVID-19 細分市場將佔據產業主導地位。這是由於為了減少病毒傳播而在測試上投入了大量資金。
  • 中心實驗室細分市場在 2023 年佔據最高的收益佔有率，因為與PoC 和家庭測試相比，實驗室測試具有更高的準確性和可靠性；與其他兩個細分市場相比，它具有競爭優勢。
  • 由於其有利的法規結構、注重預防和早期檢測以及新診斷方法的高採用率，北美將在 2023 年主導全球產業。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章感染疾病體外診斷市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 感染疾病體外診斷市場分析工具
    • 波特的分析
    • PESTEL分析

第4章感染疾病體外診斷市場：依產品估計及趨勢分析

  • 細分儀表板
  • 感染疾病體外診斷市場：2023 年及 2030 年產品變化分析
  • 裝置
  • 試劑
  • 軟體

第5章感染疾病體外診斷市場：技術估計與趨勢分析

  • 細分儀表板
  • 感染疾病體外診斷市場：2023 年與 2030 年技術變遷分析
  • 免疫檢測
  • 分子診斷
  • 微生物學
  • 其他

第6章感染疾病體外診斷市場：按應用估計和趨勢分析

  • 細分儀表板
  • 感染疾病體外診斷市場：2023 年和 2030 年應用變化分析
  • MRSA
  • 鏈球菌
  • 困難梭狀芽孢桿菌
  • ＶＲＥ
  • 創新的
  • 呼吸道病毒
  • 念珠菌屬
  • 結核病和抗藥性結核病
  • 胃腸道測試
  • 披衣菌感染
  • 淋病
  • HPV
  • HIV
  • C型肝炎
  • B型肝炎
  • COVID-19
  • 其他感染疾病

第7章感染疾病體外診斷市場：依檢測地點估算與趨勢分析

  • 細分儀表板
  • 感染疾病體外診斷市場：2023 年和 2030 年測試地點變化分析
  • 注意事項
  • 中央研究院
  • 其他

第8章感染疾病體外診斷市場：區域估計與趨勢分析

  • 2023年及2030年按地區分類的感染疾病診斷市場佔有率
  • 北美洲
    • 2018-2030年北美感染疾病體外診斷市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲感染疾病體外診斷市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 2018-2030年亞太感染疾病體外診斷市場估計與預測
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年拉丁美洲感染疾病體外診斷市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東和非洲感染疾病體外診斷市場估計與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司市場佔有率分析
  • 企業熱力圖分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • QIAGEN
    • BD
    • bioMerieux SA
    • F. Hoffmann-La Roche, Ltd.
    • Hologic, Inc.（Gen Probe）
    • Abbott
    • Quidel Corporation
    • Siemens Healthineers AG
    • Bio-Rad Laboratories, Inc.
    • Danaher
    • OraSure Technologies, Inc.
Product Code: 978-1-68038-716-2

Infectious Disease In Vitro Diagnostics Market Growth & Trends:

The global infectious disease in vitro diagnostics market size is expected to reach USD 28.05 billion by 2030, registering a CAGR of 2.4% during the forecast period, according to a new report by Grand View Research, Inc. The rising prevalence of infectious diseases, such as tuberculosis & COVID-19, and technological advancements are projected to drive the product demand in the coming years. The rising prevalence of multi-drug resistant infections is enhancing the early diagnosis of infectious diseases. For instance, MDR infections are highly common in ICU patients, as per the Microbial Drug Resistance Journal in 2021, the prevalence of MDR infections in critically ill SARS-CoV-2 patients ranged between14% and 50%.

The delay in diagnosis and treatment with antibiotics before infection diagnosis is further escalating the prevalence of drug resistant-bacteria, creating a lucrative opportunity for industry growth. The industry is witnessing a significant number of product launches to meet the demands of consumers. For instance, in May 2022, BD introduced its automated diagnostic platform for infectious diseases in the U.S. The system allows the loading of 1700 specimens and the need for specimen sorting is also eliminated, thereby, reducing errors. Products offered by various competitors have been strategically priced to increase competitive rivalry.

However, complexity in buying behavior increases prominently when consumers have to choose between PoC and lab-based tests owing to differences in sensitivity and beliefs. The industry is oligopolistic with companies, such as Hoffmann-La Roche Ltd., Alere, bioMerieux, and BD, holding the majority of the share collectively. The global industry is price-sensitive, creating rigorous competition among players in terms of manufacturing cost-effective and efficient products. Competitive rivalry is estimated to increase during the forecast period owing to the expected launch of novel biomarker kits. Competitors are adopting key strategies, such as product launches and organizing awareness programs, to gain higher market shares.

Infectious Disease In Vitro Diagnostics Market Report Highlights:

  • The reagents product segment held the largest revenue share in 2023 owing to its high-volume usage in testing
  • The molecular diagnostics segment held the largest share in 2023 owing to an increased number of product launches in the segment and increased adoption due to its high accuracy
  • By application, the COVID-19 segment dominated the industry in 2023 due to the high expenditure on testing, to reduce the spread of the virus
  • The central laboratories segment held the highest revenue share in 2023 due to the higher accuracy of laboratory-based tests, which makes them more reliable as compared to PoC and home tests, giving these tests a competitive edge over the other two segments
  • North America dominated the global industry in 2023 due to its favorable regulatory framework, focus on preventive & early testing, and the higher adoption rate of novel diagnostics in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product
    • 1.2.2. Technology
    • 1.2.3. Application
    • 1.2.4. Test Location
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Infectious Disease In Vitro Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Growing geriatric population
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. High demand for PoC facilities
      • 3.2.1.4. Increasing prevalence of infectious diseases
      • 3.2.1.5. External funding for R&D activities
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High prices of IVD tests
  • 3.3. Infectious Disease In Vitro Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape

Chapter 4. Infectious Disease In Vitro Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Infectious Disease In Vitro Diagnostics Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Instruments
    • 4.3.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Reagents
    • 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.5. Software
    • 4.5.1. Software Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Infectious Disease In Vitro Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Infectious Disease In Vitro Diagnostics Market: Technology Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Immunoassay
    • 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Molecular Diagnostics
    • 5.4.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. Microbiology
    • 5.5.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Infectious Disease In Vitro Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Infectious Disease In Vitro Diagnostics Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. MRSA
    • 6.3.1. MRSA Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Streptococcus
    • 6.4.1. Streptococcus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Clostridium difficile
    • 6.5.1. Clostridium difficile Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. VRE
    • 6.6.1. VRE Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. CRE
    • 6.7.1. CRE Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Respiratory Virus
    • 6.8.1. Respiratory Virus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Candida
    • 6.9.1. Candida Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.10. TB and drug-resistant TB
    • 6.10.1. TB and Drug-resistant TB Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.11. Gastro-intestinal panel testing
    • 6.11.1. Gastro-intestinal Panel Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.12. Chlamydia
    • 6.12.1. Chlamydia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.13. Gonorrhea
    • 6.13.1. Gonorrhea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.14. HPV
    • 6.14.1. HPV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.15. HIV
    • 6.15.1. HIV Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.16. Hepatitis C
    • 6.16.1. Hepatitis C Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.17. Hepatitis B
    • 6.17.1. Hepatitis B Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.18. COVID-19
    • 6.18.1. COVID-19 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.19. Other Infectious Diseases
    • 6.19.1. Others Market Revenue Estimates and Forecasts, 2018 -

Chapter 7. Infectious Disease In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Infectious Disease In Vitro Diagnostics Market: Test Location Movement Analysis, 2023 & 2030 (USD Billion)
  • 7.3. Point of Care
    • 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Central Laboratories
    • 7.4.1. Central Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Others
    • 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Infectious Disease In Vitro Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. Infectious Disease In Vitro Diagnostics Market Share, By Region, 2023 & 2030 (USD Billion)
  • 8.2. North America
    • 8.2.1. North America Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.2.2.3. Competitive Insights
      • 8.2.2.4. U.S. Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.2.3.3. Competitive Insights
      • 8.2.3.4. Canada Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.2. U.K.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.2.3. Competitive Insights
      • 8.3.2.4. U.K. Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.3.3. Competitive Insights
      • 8.3.3.4. Germany Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.4.3. Competitive Insights
      • 8.3.4.4. France Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.5.3. Competitive Insights
      • 8.3.5.4. Italy Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.6.3. Competitive Insights
      • 8.3.6.4. Spain Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.7. Sweden
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.7.3. Competitive Insights
      • 8.3.7.4. Sweden Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.8.3. Competitive Insights
      • 8.3.8.4. Denmark Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.9.3. Competitive Insights
      • 8.3.9.4. Norway Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.2. China
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. China Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Japan Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. India Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.5.3. Competitive Insights
      • 8.4.5.4. South Korea Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.6.3. Competitive Insights
      • 8.4.6.4. Australia Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.7.3. Competitive Insights
      • 8.4.7.4. Thailand Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. Brazil Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Mexico Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. Argentina Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Saudi Arabia Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.3. UAE
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. UAE Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.4. South Africa
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. South Africa Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. Kuwait Infectious Disease In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
  • 9.6. Company Profiles
    • 9.6.1. QIAGEN
      • 9.6.1.1. Participant's Overview
      • 9.6.1.2. Financial Performance
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Recent Developments
    • 9.6.2. BD
      • 9.6.2.1. Participant's Overview
      • 9.6.2.2. Financial Performance
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Recent Developments
    • 9.6.3. bioMerieux SA
      • 9.6.3.1. Participant's Overview
      • 9.6.3.2. Financial Performance
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Recent Developments
    • 9.6.4. F. Hoffmann-La Roche, Ltd.
      • 9.6.4.1. Participant's Overview
      • 9.6.4.2. Financial Performance
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Recent Developments
    • 9.6.5. Hologic, Inc. (Gen Probe)
      • 9.6.5.1. Participant's Overview
      • 9.6.5.2. Financial Performance
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Recent Developments
    • 9.6.6. Abbott
      • 9.6.6.1. Participant's Overview
      • 9.6.6.2. Financial Performance
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Recent Developments
    • 9.6.7. Quidel Corporation
      • 9.6.7.1. Participant's Overview
      • 9.6.7.2. Financial Performance
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Recent Developments
    • 9.6.8. Siemens Healthineers AG
      • 9.6.8.1. Participant's Overview
      • 9.6.8.2. Financial Performance
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Recent Developments
    • 9.6.9. Bio-Rad Laboratories, Inc.
      • 9.6.9.1. Participant's Overview
      • 9.6.9.2. Financial Performance
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Recent Developments
    • 9.6.10. Danaher
      • 9.6.10.1. Participant's Overview
      • 9.6.10.2. Financial Performance
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Recent Developments
    • 9.6.11. OraSure Technologies, Inc.
      • 9.6.11.1. Participant's Overview
      • 9.6.11.2. Financial Performance
      • 9.6.11.3. Product Benchmarking
      • 9.6.11.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global IVD Infectious Diseases Market, By Region, 2018 - 2030 (USD Billion)
  • Table 5 Global IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 6 Global IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 7 Global IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 8 Global IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 9 North America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
  • Table 10 North America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 11 North America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 12 North America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 13 North America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 14 U.S. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 15 U.S. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 16 U.S. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 18 Canada IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 19 Canada IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 20 Canada IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 21 Canada IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 22 Europe IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
  • Table 23 Europe IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 24 Europe IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 25 Europe IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 26 Europe IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 27 U.K. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 28 U.K. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 29 U.K. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 31 Germany IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 32 Germany America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 33 Germany America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 35 France IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 36 France IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 37 France IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 38 France IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 39 Spain IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 40 Spain IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 41 Spain IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 42 Spain IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 43 Italy IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 44 Italy IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 45 Italy IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 46 Italy IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 47 Denmark IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 48 Denmark IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 49 Denmark IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 50 Denmark IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 51 Sweden IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 52 Sweden IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 53 Sweden IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 54 Sweden IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 55 Norway IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 56 Norway IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 57 Norway IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 58 Norway IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 59 Asia Pacific IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
  • Table 60 Asia Pacific IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 61 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 62 Asia Pacific IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 63 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 64 China IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 65 China IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 66 China IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 67 China IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 68 Japan IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 69 Japan IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 70 Japan IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 71 Japan IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 72 India IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 73 India IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 74 India IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 75 India IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 76 South Korea IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 77 South Korea IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 78 South Korea IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 79 South Korea IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 80 Thailand IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 81 Thailand IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 82 Thailand IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 83 Thailand IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 84 Australia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 85 Australia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 86 Australia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 87 Australia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 88 Latin America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
  • Table 89 Latin America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 90 Latin America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 91 Latin America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 92 Latin America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 93 Brazil IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 94 Brazil IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 95 Brazil IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 96 Brazil IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 97 Mexico IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 98 Mexico IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 99 Mexico IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 100 Mexico IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 101 Argentina IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 102 Argentina IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 103 Argentina IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 104 Argentina IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 105 MEA IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
  • Table 106 MEA IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 107 MEA IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 108 MEA IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 109 MEA IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 110 South Africa IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 111 South Africa IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 112 South Africa IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 113 South Africa IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 114 UAE IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 115 UAE IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 116 UAE IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 117 UAE IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 118 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 119 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 120 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 121 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
  • Table 122 Kuwait IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
  • Table 123 Kuwait IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
  • Table 124 Kuwait IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
  • Table 125 Kuwait IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 IVD infectious diseases market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Primary interviews in North America
  • Fig. 6 Primary interviews in Europe
  • Fig. 7 Primary interviews in Asia Pacific
  • Fig. 8 Primary interviews in Middle East and Africa
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 IVD infectious disease market snapshot
  • Fig. 14 Segment Insights
  • Fig. 15 Strategy framework
  • Fig. 16 Penetration & growth prospect mapping
  • Fig. 17 Consumer behavior analysis
  • Fig. 18 Factors influencing North America IVD infectious diseases market (%)
  • Fig. 19 Factors influencing Europe IVD infectious diseases market (%)
  • Fig. 20 Factors influencing Asia Pacific IVD infectious diseases market (%)
  • Fig. 21 Factors influencing Latin America IVD infectious diseases market (%)
  • Fig. 22 Factors influencing Middle East and Africa IVD infectious diseases market (%)
  • Fig. 23 Market driver relevance analysis (Current & future impact)
  • Fig. 24 Global population growth, by age-group, 2012 - 2022 (Million)
  • Fig. 25 Global percentage of population, by age group, 2000 and 2050
  • Fig. 26 General trend of CLIA-waived tests
  • Fig. 27 Market restraint relevance analysis (Current & future impact)
  • Fig. 28 Porter's five forces analysis
  • Fig. 29 PESTLE analysis
  • Fig. 30 Strategy mapping
  • Fig. 31 IVD infectious diseases market: Product movement analysis
  • Fig. 32 Product segment dashboard
  • Fig. 33 IVD infectious diseases market product outlook: Key takeaways
  • Fig. 34 Instruments market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 35 Reagents market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 36 Software market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 37 IVD infectious diseases market: Technology movement analysis
  • Fig. 38 Technology segment dashboard
  • Fig. 39 IVD infectious diseases market technology outlook: Key takeaways
  • Fig. 40 Immunoassay market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 41 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 42 PCR market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 43 In Situ Hybridization market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 44 INAAT market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 45 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 46 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 47 TMA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 48 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 49 Microbiology market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 50 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 51 IVD infectious diseases market: Technology movement analysis
  • Fig. 52 Application segment dashboard
  • Fig. 53 IVD infectious diseases market technology outlook: Key takeaways
  • Fig. 54 MRSA market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 55 Streptococcus market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 56 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 57 VRE market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 58 CRE market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 59 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 60 Candida market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 61 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 62 GI panel testing market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 63 Chlamydia market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 64 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 65 HPV market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 66 HIV market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 67 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 68 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 69 COVID-19 market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 70 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 71 IVD infectious diseases market: Test location movement analysis
  • Fig. 72 Test location segment dashboard
  • Fig. 73 IVD infectious diseases market test location outlook: Key takeaways
  • Fig. 74 Point of Care market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 75 Central laboratories market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 76 Others market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 77 Regional outlook, 2023 & 2030
  • Fig. 78 Regional market dashboard
  • Fig. 79 Regional marketplace: Key takeaways
  • Fig. 80 North America market share and leading players, 2023
  • Fig. 81 Europe market share and leading players, 2023
  • Fig. 82 Asia Pacific market share and leading players, 2023
  • Fig. 83 Latin America market share and leading players, 2023
  • Fig. 84 Middle East and Africa market share and leading players, 2023
  • Fig. 85 North America, SWOT
  • Fig. 86 Europe, SWOT
  • Fig. 87 Asia Pacific, SWOT
  • Fig. 88 Latin America, SWOT
  • Fig. 89 Middle East and Africa, SWOT
  • Fig. 90 North America IVD infectious diseases market, 2018 - 2030 (USD Billion)
  • Fig. 91 U.S. key country dynamics
  • Fig. 92 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 93 Canada key country dynamics
  • Fig. 94 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 95 Europe IVD infectious diseases market, 2018 - 2030 (USD Billion)
  • Fig. 96 UK key country dynamics
  • Fig. 97 UK IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 98 Germany key country dynamics
  • Fig. 99 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 100 Spain key country dynamics
  • Fig. 101 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 102 France key country dynamics
  • Fig. 103 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 104 Italy key country dynamics
  • Fig. 105 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 106 Denmark key country dynamics
  • Fig. 107 Denmark IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 108 Sweden key country dynamics
  • Fig. 109 Sweden IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 110 Norway key country dynamics
  • Fig. 111 Norway IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 112 Asia Pacific IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 113 Japan key country dynamics
  • Fig. 114 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 115 China key country dynamics
  • Fig. 116 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 117 India key country dynamics
  • Fig. 118 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 119 South Korea key country dynamics
  • Fig. 120 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 121 Australia key country dynamics
  • Fig. 122 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 123 Thailand key country dynamics
  • Fig. 124 Thailand IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 125 Latin America IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 126 Brazil key country dynamics
  • Fig. 127 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 128 Mexico key country dynamics
  • Fig. 129 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 130 Argentina key country dynamics
  • Fig. 131 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 132 MEA IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 133 South Africa key country dynamics
  • Fig. 134 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 135 Saudi Arabia key country dynamics
  • Fig. 136 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 137 UAE key country dynamics
  • Fig. 138 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 139 Kuwait key country dynamics
  • Fig. 140 Kuwait IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
  • Fig. 141 Ansoff Matrix
  • Fig. 142 Heat map analysis
  • Fig. 143 Company market share analysis,2023
  • Fig. 144 Company market position analysis
  • Fig. 145 Market differentiators